Evaluation and comparison of expectant treatment and drug treatment on retained products of concepto
Phase 2
- Conditions
- Abortion.Complications following ectopic and molar pregnancy
- Registration Number
- IRCT20240514061800N3
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 124
Inclusion Criteria
Patients with no history of previous abortion
Patients without underlying disease
Patients who have informed consent to participate in the study
Exclusion Criteria
Patients with a history of previous abortion
Patients with underlying disease
Patients who do not have informed consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of menstrual intervals. Timepoint: Every 2 weeks for a maximum of 6 weeks. Method of measurement: Using an ultrasound scan.;Improvement of vaginal bleeding. Timepoint: Every 2 weeks for a maximum of 6 weeks. Method of measurement: Using an ultrasound scan.
- Secondary Outcome Measures
Name Time Method